|
SLC35B4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.771330E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.749900E-02 |
| Normal-vs-Stage2 |
2.064900E-03 |
| Normal-vs-Stage3 |
3.846100E-04 |
| Normal-vs-Stage4 |
3.954900E-04 |
| Stage1-vs-Stage2 |
4.547700E-02 |
| Stage1-vs-Stage3 |
2.633600E-02 |
| Stage1-vs-Stage4 |
3.033800E-02 |
| Stage2-vs-Stage3 |
8.116800E-01 |
| Stage2-vs-Stage4 |
8.869400E-01 |
| Stage3-vs-Stage4 |
9.078000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.815600E-04 |
| Normal-vs-AfricanAmerican |
2.541300E-03 |
| Normal-vs-Asian |
1.237220E-03 |
| Caucasian-vs-AfricanAmerican |
1.785390E-01 |
| Caucasian-vs-Asian |
1.727770E-01 |
| AfricanAmerican-vs-Asian |
4.494600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76325999999838E-05 |
| Normal-vs-Female |
6.531900E-02 |
| Male-vs-Female |
2.678300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.255100E-03 |
| Normal-vs-Age(41-60Yrs) |
2.156400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.001760E-03 |
| Normal-vs-Age(81-100Yrs) |
1.237550E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.364000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.709800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.265600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.610000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.936800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.415600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.757800E-01 |
| Normal-vs-Grade 2 |
2.106300E-02 |
| Normal-vs-Grade 3 |
7.776500E-04 |
| Normal-vs-Grade 4 |
3.31590000002269E-06 |
| Grade 1-vs-Grade 2 |
4.045000E-01 |
| Grade 1-vs-Grade 3 |
3.830400E-01 |
| Grade 1-vs-Grade 4 |
1.245010E-01 |
| Grade 2-vs-Grade 3 |
2.943600E-01 |
| Grade 2-vs-Grade 4 |
4.002800E-03 |
| Grade 3-vs-Grade 4 |
2.050400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.574000E-01 |
| Normal-vs-ccB subtype |
4.58899999999929E-07 |
| ccA subtype-vs-ccB subtype |
3.89059999994501E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.655700E-03 |
| Normal-vs-N1 |
1.814030E-02 |
| N0-vs-N1 |
7.556200E-02 |
|
|
